primary aldosteronism
Conditions
Sponsors
Sun Yat-sen Memorial Hospital
Eligibility
Sex/Gender
All
Age
15 Years to 90 Years
Inclusion criteria
Inclusion criteria: (1) Experimental group: patients clinically diagnosed as primary aldosteronism (PA group); (2) Control group: patients with essential hypertension (EH group) matched by gender and age (+/-2 years).
Exclusion criteria
Exclusion criteria: (1) Patients with missing main study parameters, such as RAAS-related indicators and thyroid-related parameters; (2) PA patients who have received normal treatment and reached the treatment standard (aldosterone reduced to the normal range, renin activity unsurpressed, spontaneous hypokalemia corrected, etc.) were excluded; (3) Severe organ damage in heart, liver, kidney and brain, pregnant women, or taking drugs that affect thyroid function.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the prevalence of thyroid nodules;T3;T4;TSH;TPOAb;TGAb;serum iron;total iron-binding capacity;transferrin;serum potassium;serum calcium;fasting blood glucose;HbA1c;plasma aldosterone concentration;plasma renin activity;aldosterone-renin ratio;eGFR; | — |
Countries
China
Contacts
Public ContactGuo Ying
Sun Yat-sen Memorial Hospital
Outcome results
None listed